The North America human drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
Key factors that are driving the growth of the market are rising need for medication among the populace, extensive research and developments projects undertaken by various market players to sustain their leadership in the market leading to launch of new and innovative products as well as a well-established pharmaceutical and medical device industry in the region.
Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to the increasing prevalence of the chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. Also, cancer is one of the leading cause of death in the North America region. Furthermore, the American Cancer Society (ACS) estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed. Targeted drug delivery system (TDDS) is a system, which delivers the drug in a controlled manner at a preselected biosite. Diabetes is a life-threatening chronic disease with no specialized cure. Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. For instance, according to the International Diabetes Federation (IDF), in 2017, a number of people with diabetes in North America was approximately 46 million, which is expected to reach 62 million in 2045. Thus, the increasing number of patients suffering from one or more chronic diseases is expected to boost the growth of drug delivery devices market over the coming years.
The US drug delivery systems market is expected to grow at the highest rate during the forecast period. The growth of this market is primarily driven by increasing prevalence of chronic diseases like diabetes, asthma, and others, a growing number of product launches by key players; and increasing use of drug delivery systems for disease management. The market for drug delivery systems in the US region is expected to reach US$ 741,528.96 Mn in 2027 from US$ 388,359.24 Mn in 2018. The growth rate of the market in the region is estimated to be 7.6% during the forecast period.
North America Drug Delivery Systems Market Revenue and Forecasts to 2027 ( US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION
By Route of Administration
- Oral
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-solid Oral Drugs
- Transmucosal
- Pulmonary Drug Delivery
- In-metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Buccal Drug Delivery
- Sublingual Drug Delivery
- Rectal Transmucosal Drug delivery
- Vaginal Transmucosal Drug Delivery
- Pulmonary Drug Delivery
- Injectable
- Conventional Injection Devices
- Self-Injection Devices
- Needle Free Injectors
- Pen Injectors
- Wearable Injectors
- Topical
- Semi-solid Topical Drug Delivery Formulations
- Liquid Topical Drug Delivery Formulations
- Solid Topical Drug Delivery Formulations
- Transdermal Patches
- Transdermal Gels
- Others
- Implantable
- Active Implantable
- Passive Implantable
- Ocular
- Eye Drops & Sprays
- Gels & Ointments
- Ocular Inserts
- Drug Coated Contact Lenses
NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Application
- Hospital & Clinics
- Home Care Settings
- Others
NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- U.S
- Canada
- Mexico
Companies Mentioned
- BD
- Novo Nordisk A/S
- 3M
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
North America Drug Delivery Systems Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 572,453.0 Million |
| Market Size by 2027 | US$ 1,074,679.7 Million |
| Global CAGR (2019 - 2027) | 7.4% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Aquaculture Market
- Organoids Market
- Retinal Imaging Devices Market
- Emergency Department Information System (EDIS) Market
- Resistance Bands Market
- Batter and Breader Premixes Market
- Piling Machines Market
- Health Economics and Outcome Research (HEOR) Services Market
- Third Party Logistics Market
- Microplate Reader Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Route of Administration, Distribution Channel, and Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
Trends and growth analysis reports related to Medical Device : READ MORE..
The List of Companies - North America Drug Delivery Systems Market
1. BD 2. Novo Nordisk A/S 3. 3M4. Boston Scientific Corporation 5. Bausch Health Companies Inc. 6. Baxter International, Inc. 7. Boehringer Ingelheim 8. Novartis AG9. GlaxoSmithKline plc. 10. Johnson & Johnson Services, Inc.
Get Free Sample For